ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
OnJanuary 9, 2023 , in advance of a public webcast presentation at theJ.P. Morgan Healthcare Conference onJanuary 10, 2023 Danaher Corporation issued a press release regarding the Company's anticipated financial performance for the fourth quarter of 2022 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher's anticipated financial performance for 2022. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits: Exhibit No. Description 99.1 Press release - "Danaher CEO to
Comment on Financial Performance"
99.1PRE Selected Danaher Presentation
Slides for
Conference onJanuary 10, 2023 104 Cover Page Interactive Data File
(formatted as inline XBRL with applicable
taxonomy extension information contained in Exhibits 101)
--------------------------------------------------------------------------------
© Edgar Online, source